美国临床内分泌医师协会/美国内分泌学会血脂异常管理与心血管疾病预防临床实践指南
American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice Guidelines.
作者信息
Jellinger Paul S
机构信息
Center for Diabetes & Endocrine Care, Hollywood, FL, and University of Miami Miller School of Medicine, Miami, FL.
出版信息
Diabetes Spectr. 2018 Aug;31(3):234-245. doi: 10.2337/ds18-0009.
Abstract
In February 2017, the American Association of Clinical Endocrin-ologists and the American College of Endocrinology published updated "Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease." The update encompassed recent important clinical trial outcomes and additional research related to the treatment of dyslipidemia. This article summarizes key recommendations from this important guideline.
摘要
2017年2月，美国临床内分泌医师协会和美国内分泌学会发表了更新后的《血脂异常管理与心血管疾病预防指南》。此次更新涵盖了近期重要的临床试验结果以及与血脂异常治疗相关的其他研究。本文总结了这一重要指南的关键建议。
相似文献
1
American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice Guidelines.美国临床内分泌医师协会/美国内分泌学会血脂异常管理与心血管疾病预防临床实践指南
Diabetes Spectr. 2018 Aug;31(3):234-245. doi: 10.2337/ds18-0009.
2
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.美国临床内分泌医师协会和美国内分泌学会血脂异常管理与心血管疾病预防指南
Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL.
3
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARY.美国临床内分泌医师协会和美国内分泌学会血脂异常管理和心血管疾病预防指南 - 执行摘要。
Endocr Pract. 2017 Apr 2;23(4):479-497. doi: 10.4158/EP171764.GL. Epub 2017 Feb 3.
4
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.美国临床内分泌医师协会和美国内分泌学会成人生长激素缺乏症管理指南以及儿科向成人保健过渡患者的指南。
Endocr Pract. 2019 Nov;25(11):1191-1232. doi: 10.4158/GL-2019-0405.
5
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines.美国临床内分泌医师协会和美国内分泌学会肥胖患者医疗护理综合临床实践指南执行摘要完整指南可在https://www.aace.com/publications/guidelines获取。
Endocr Pract. 2016 Jul;22(7):842-84. doi: 10.4158/EP161356.ESGL.
6
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE.美国临床内分泌医师协会/美国内分泌学会 2020 年绝经后骨质疏松症诊断和治疗临床实践指南更新版
Endocr Pract. 2020 May;26(Suppl 1):1-46. doi: 10.4158/GL-2020-0524SUPPL.
7
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.美国临床内分泌医师协会和美国内分泌学会肥胖患者医疗护理综合临床实践指南
Endocr Pract. 2016 Jul;22 Suppl 3:1-203. doi: 10.4158/EP161365.GL. Epub 2016 May 24.
8
CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - .肥胖患者减重手术围手术期营养、代谢和非手术支持临床实践指南-2019 年更新：美国临床内分泌医师协会/美国内分泌学会、肥胖协会、美国代谢与减重外科学会、肥胖医学协会和美国麻醉师协会共同赞助
Endocr Pract. 2019 Dec;25(12):1346-1359. doi: 10.4158/GL-2019-0406. Epub 2019 Nov 4.
9
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.美国临床内分泌医师协会和美国内分泌学会关于绝经的立场声明 - 2017年更新版
Endocr Pract. 2017 Jul;23(7):869-880. doi: 10.4158/EP171828.PS.
10
ADIPOSITY-BASED CHRONIC DISEASE AS A NEW DIAGNOSTIC TERM: THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT.基于肥胖的慢性疾病作为一个新的诊断术语：美国临床内分泌医师协会和美国内分泌学会立场声明。
Endocr Pract. 2017 Mar;23(3):372-378. doi: 10.4158/EP161688.PS. Epub 2016 Dec 14.
引用本文的文献
1
Distinct cytokine profiles associated with malnutrition, dyslipidemia and kidney dysfunction in patients with diabetic foot ulcer.糖尿病足溃疡患者中与营养不良、血脂异常和肾功能不全相关的独特细胞因子谱。
Sci Rep. 2025 Jul 1;15(1):21138. doi: 10.1038/s41598-025-08145-5.
2
A framework for detecting causal effects of risk factors at an individual level based on principles of Mendelian randomisation: applications to modelling individualised effects of lipids on coronary artery disease.基于孟德尔随机化原理在个体水平检测风险因素因果效应的框架：脂质对冠状动脉疾病个体化效应建模的应用
EBioMedicine. 2025 Mar;113:105616. doi: 10.1016/j.ebiom.2025.105616. Epub 2025 Feb 28.
3
Differential seasonal performance of C3-epi-D3 level and proportion on multiple metabolic disorders in patients with type 2 diabetes mellitus.2型糖尿病患者中C3-表-D3水平及比例在多种代谢紊乱方面的季节性差异表现
Eur J Med Res. 2024 Dec 23;29(1):617. doi: 10.1186/s40001-024-02212-9.
4
Obesity Defining Criteria, and Association with Cardiovascular Disease Risk Factors Among People Living with HIV in Jos, Nigeria.尼日利亚乔斯地区HIV感染者的肥胖定义标准及其与心血管疾病风险因素的关联
Niger Med J. 2024 Sep 26;65(4):490-502. doi: 10.60787/nmj-v65i3-478. eCollection 2024 Jul-Aug.
5
Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world.现实世界中载脂蛋白B和脂蛋白(a)检测的低普及率。
Am J Prev Cardiol. 2024 Aug 16;19:100721. doi: 10.1016/j.ajpc.2024.100721. eCollection 2024 Sep.
6
The Protocol for the Development of Iranian Clinical Practice Guideline on Dyslipidemia.伊朗血脂异常临床实践指南制定方案
ARYA Atheroscler. 2023 Nov-Dec;19(6):27-35. doi: 10.48305/arya.2023.41868.2904.
7
Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score‑matched analysis.钠-葡萄糖共转运蛋白 2 抑制剂与急性冠状动脉综合征 2 型糖尿病患者主要不良心血管事件风险的相关性：倾向评分匹配分析。
Cardiovasc Diabetol. 2024 Mar 25;23(1):106. doi: 10.1186/s12933-024-02200-7.
8
A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids.残余心血管疾病风险管理的实用方法：阿联酋二十碳五烯酸乙酯和欧米伽-3脂肪酸证据专家共识小组
Cardiovasc Drugs Ther. 2024 Feb 16. doi: 10.1007/s10557-023-07519-z.
9
Dyslipidemia in diabetes.糖尿病患者的血脂异常。
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S80-S82. doi: 10.1016/j.ihj.2023.11.002. Epub 2023 Nov 11.
10
Physicians' perceptions and beliefs on the current dyslipidemia management practices within Saudi Arabia.沙特阿拉伯内科医生对当前血脂异常管理实践的认知与看法。
Saudi Pharm J. 2023 Oct;31(10):101759. doi: 10.1016/j.jsps.2023.101759. Epub 2023 Aug 23.
本文引用的文献
1
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.美国临床内分泌医师协会和美国内分泌学会血脂异常管理与心血管疾病预防指南
Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL.
2
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.依洛尤单抗与心血管疾病患者的临床结局。
N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17.
3
Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA).冠状动脉钙化评分为零及其他心血管疾病阴性风险标志物的作用：动脉粥样硬化多民族研究（MESA）
Circulation. 2016 Mar 1;133(9):849-58. doi: 10.1161/CIRCULATIONAHA.115.018524. Epub 2016 Jan 22.
4
Familial hypercholesterolemia: Review of diagnosis, screening, and treatment.家族性高胆固醇血症：诊断、筛查及治疗综述
Can Fam Physician. 2016 Jan;62(1):32-7.
5
How Do PCSK9 Inhibitors Stack Up to Statins for Low-Density Lipoprotein Cholesterol Control?在控制低密度脂蛋白胆固醇方面，前蛋白转化酶枯草溶菌素9（PCSK9）抑制剂与他汀类药物相比情况如何？
Am Health Drug Benefits. 2015 Nov;8(8):436-42.
6
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).辛伐他汀联合依泽替米贝用于慢性肾脏病心血管预防的成本效益：心脏和肾脏保护研究（SHARP）结果
Am J Kidney Dis. 2016 Apr;67(4):576-84. doi: 10.1053/j.ajkd.2015.09.020. Epub 2015 Nov 18.
7
10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study).利用冠状动脉钙化和传统危险因素预测10年冠心病风险：在动脉粥样硬化多民族研究（MESA）中进行推导，并在海因茨·尼克斯多夫召回研究（HNR）和达拉斯心脏研究（DHS）中进行验证。
J Am Coll Cardiol. 2015 Oct 13;66(15):1643-53. doi: 10.1016/j.jacc.2015.08.035.
8
Association of Cardiometabolic Multimorbidity With Mortality.心脏代谢多重疾病与死亡率的关联
JAMA. 2015 Jul 7;314(1):52-60. doi: 10.1001/jama.2015.7008.
9
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.依折麦布联合他汀类药物治疗急性冠脉综合征。
N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.
10
Familial hypercholesterolemia.家族性高胆固醇血症
Cardiol Clin. 2015 May;33(2):169-79. doi: 10.1016/j.ccl.2015.01.001.
Zotero 插件